SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):100P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Smith-Jones, P.
Right arrow Articles by Larson, S.
PubMed
Right arrow Articles by Smith-Jones, P.
Right arrow Articles by Larson, S.

Oncology-Basic Science: Basic Science

Correlative Studies

Ex vivo correlation of antigen expression with uptake of 124I-huA33 in humans

Peter Smith-Jones1, Joseph O'Donoghue2, John Humm2, Philip Paty3, Yuman Fong3, Douglas Wong3, Chaitanya Divgi1, Lloyd Old4 and Steve Larson1

1 Radiology; 2 Medical Physics; 3 Surgery, MSKCC, New York, New York; 4 LICR, New York, New York

399

Objectives: Compare the ex vivo uptake of a radiolabeled antibody with the tissue antigen expression.

Methods: All studies were performed under an IRB approved protocol and only patients scheduled for surgery were included. Patients, with known colon cancer disease, were injected with 4-10 mCi of 124I-huA33 (10 mg huA33) and imaged with a clinical PET scanner at 4-6 days post injection. After PET imaging, the patients underwent surgery and the tumor masses were removed. Portions of the tumor and normal tissue samples were counted in a gamma counter and tissue membranes prepared. The membranes were assayed for protein content and then used in saturation binding studies with 131I-huA33 to determine the numbers of receptors present and the antibody/antigen binding affinity (experimental control). The data were plotted as the 124I-huA33 uptake (%ID/g) against the A33 antigen expression (pmoles/mg protein).

Results: 24 tumor and 26 normal samples were obtained from 8 patients. The plot of the tumor uptake against antigen expression was linear with a slope of 77 nmoles/%ID (R2 0.65). The plot of the normal uptake against antigen expression was linear with a slope of 105 nmoles/%ID (R2 = 0.62). Despite the differing sampling times (for 5 to 8 days) there were no significant differences for the individual data (slopes of 72, 79 and 82 nmoles/%ID for 5, 6 and 8 days respectively).

Conclusions: This study shows that, for the non internalizing A33 antigen, the tissue uptake of 124I-huA33 is directly proportional to the tissue expression of A33. We also found little variation between 5 and 8 days post injection. The data is now being correlated with the PET derived uptake values.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Smith-Jones, P.
Right arrow Articles by Larson, S.
PubMed
Right arrow Articles by Smith-Jones, P.
Right arrow Articles by Larson, S.